Koppelmans V et al., 2012-04-01: Case-cohort study comparing 196 breast cancer survivors treated with CMF chemotherapy about 21 years earlier against 1,509 women never diagnosed with cancer. Exposed women scored worse on memory, processing speed and executive function.
The women exposed to chemotherapy performed significantly worse than the reference group on cognitive tests of immediate (P = .015) and delayed verbal memory (P = .002), processing speed (P < .001), executive functioning (P = .013), and psychomotor speed (P = .001).
Abstract (Results)
Koppelmans V et al., 2012-04-01: Case-cohort study comparing 196 breast cancer survivors treated with CMF chemotherapy about 21 years earlier against 1,509 women never diagnosed with cancer. Exposed women scored worse on memory, processing speed and executive function. Comparator: population-based sample of women never diagnosed with cancer (no chemotherapy, no cancer). Funder/COI not in the abstract. Important for the 'lasting years' half of the claim, but note the design: it establishes a statistical deficit two decades later, not that 75% of patients are impaired. Patients on endocrine therapy were excluded. Study type: controlled study.
